Literature DB >> 4626509

Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

L S Young, D Armstrong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4626509     DOI: 10.1093/infdis/126.3.257

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  70 in total

1.  Opsonizing antibodies, host factors, and the limulus assay for endotoxin.

Authors:  L S Young
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Characterization of a protein from normal human polymorphonuclear leukocytes with bactericidal activity against Pseudomonas aeruginosa.

Authors:  C J Hovde; B H Gray
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

3.  Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  D P Speert; F Eftekhar; M L Puterman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

5.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Pollack; N L Koles; M J Preston; B J Brown; G B Pier
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.

Authors:  G K Schoolnik; T M Buchanan; K K Holmes
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

8.  Passive immunity against pseudomonas sepsis during granulocytopenia.

Authors:  L Harvath; B R Andersen; H J Amirault
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

9.  Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.

Authors:  S Hann; D S Holsclaw
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.

Authors:  A Kharazmi; N Høiby; G Döring; N H Valerius
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.